We are live on ! Find out more
FCMI

Foresite Capital Management I Portfolio holdings

AUM $21.4M
1-Year Est. Return 80.48%
This Fund
S&P 500
This Quarter Est. Return
+8.54%
1 Year Est. Return
-80.48%
3 Year Est. Return
-40.72%
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$166M
AUM Growth
-$32.4M
Cap. Flow
-$45.2M
Cap. Flow %
-27.27%
Top 10 Hldgs %
100%
Holding
4
New
–
Increased
–
Reduced
1
Closed
–

Top Buys

No buys this quarter

Top Sells

Rank Stock Value
1
TXG icon
10x Genomics
TXG
+$45.2M

Sector Composition

Rank Sector Weight
1 Healthcare 100%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
TXG icon
1
10x Genomics
TXG
$5.55B
$147M 88.53%
750,000
-250,000
-25% -$45.2M
NVAX icon
2
Novavax
NVAX
$1.35B
$14.2M 8.55%
66,810
– –
EPZM
3
DELISTED
Epizyme, Inc
EPZM
$2.44M 1.47%
293,759
– –
XLRN
4
DELISTED
Acceleron Pharma
XLRN
$2.4M 1.45%
19,100
– –

Similar funds

A
Atlassian San Francisco, California $21M AUM 71.86% 1-Year Est. Return
CVGI
Craft Ventures GP II San Francisco, California $24.1M AUM 83.06% 1-Year Est. Return
AEPI
AH Equity Partners IV Menlo Park, California $24.5M AUM 73.4% 1-Year Est. Return
AGDR
AdamCapital Gestao de Recursos Rio De Janeiro, Brazil $18.1M AUM 32.38% 1-Year Est. Return
N
NanoDimension Woodside, California $24.7M AUM 74.01% 1-Year Est. Return
WL
WiL LLC Palo Alto, California $17.5M AUM 75.04% 1-Year Est. Return
NVPX
Norwest Venture Partners XIII Palo Alto, California $25.8M AUM 76.52% 1-Year Est. Return
SVGI
Sozo Ventures GP I Redwood City, California $16.3M AUM 66.18% 1-Year Est. Return

Foresite Capital Management I's Q2 2021 Portfolio in Review

As of Q2 2021, Foresite Capital Management I held 4 positions worth $166M, down 16% from $198M the previous quarter. Its ten largest holdings account for 100% of the portfolio.

Foresite Capital Management I withdrew a net $45.2M in Q2 2021, reducing 1 holding. Its largest reduction was 10x Genomics, cutting an estimated $45.2M.

By sector, the portfolio is most concentrated in Healthcare at 100% of assets, unchanged from a quarter earlier.

  • Foresite Capital Management I's biggest Q2 2021 reduction was 10x Genomics, cutting an estimated $45.2M.
  • Foresite Capital Management I's ten largest holdings make up 100% of its $166M portfolio in Q2 2021.
  • Foresite Capital Management I opened 0 new positions and closed 0 in Q2 2021.
  • Foresite Capital Management I's portfolio value fell 16% quarter-over-quarter to $166M.

Based on Foresite Capital Management I's 13F filing for Q2 2021, filed 16 Aug 2021.